CareValidate expands HRT pathway for menopause and perimenopause care
CareValidate has launched an expanded hormone replacement therapy (HRT) pathway to help telehealth brands, employers, and healthcare businesses deliver menopause and perimenopause care. The offering combines clinical and regulatory infrastructure with licensed providers, pharmacy fulfillment, and multiple hormone therapy options, including progesterone, DHEA, and estradiol in different delivery formats. The expansion aims to simplify the launch and management of HRT programs while strengthening access to personalized women’s healthcare through clinical oversight and ongoing support.
Omada Health study links virtual GLP-1 support to improved weight loss outcomes
Omada Health reported that members using its GLP-1 Care Track achieved greater weight loss and improved body composition compared with usual care in a 12-week study of 245 adults with obesity. Participants in the virtual care program lost an average of 6.0% of their starting body weight, compared with 3.3% in the usual-care group, alongside greater reductions in body fat percentage and increases in muscle mass percentage. Published in Diabetes, Obesity and Metabolism, the findings highlight the potential of virtual coaching, nutrition guidance, exercise planning, and behavioral support to complement GLP-1 treatment.
Fangzhou partners with Cutia Therapeutics to advance AI-powered dermatology care
Fangzhou Inc. has partnered with Cutia Therapeutics to integrate dermatology treatments with AI-powered digital healthcare and long-term patient management services in China. The collaboration combines Cutia’s expertise in dermatology and hair-related conditions with Fangzhou’s digital healthcare platform and proprietary XingShi Large Language Model (XS LLM) to support personalized follow-ups, online assessments, health monitoring, and patient education. The partnership aims to improve treatment access, strengthen patient engagement, and extend care beyond individual consultations.
